Within the tissue microarray study (TMA) of Zeybek et al. [30] 95% of SCC and 81% of cervical adenocarcinomas stained positive for Trop2 with strong and diffuse expression in 71% and 56% of the tumors, respectively. The gene discussed is TACSTD2; the disease is cervical adenocarcinoma.